Myonex, a leading global clinical trial supply company, has completed the acquisition of SaveWay Compounding Pharmacy of Newark, Del. The pharmacy will operate as SaveWay Compounding Pharmacy, a Myonex company. In further pursuit of supporting clinical trial sponsor’s trial designs with direct-to-patient (DTP) and home healthcare provider (HHP) capabilities, this acquisition allows wider patient access across the entire United States, in addition to supporting patients with their access to trial medication and equipment needed.
Read the full article: Myonex Announces Acquisition of SaveWay Compounding Pharmacy to Expand Its Clinical Trial Services across the US //
Source: https://www.prnewswire.com/news-releases/myonex-announces-acquisition-of-saveway-compounding-pharmacy-to-expand-its-clinical-trial-services-across-the-us-302111199.html